Repositioning and Offloading Devices Market Players:
- Molnlycke Health Care AB
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- PfBeechfield Healthcare Ltd
- V Guldmann A/S
- Sage Products LLC
- Hill-Rom Services, Inc.
- Frontier Medical Group
- Walgreen Health Solutions, LLC.
- Stryker Corporation
- Seneca Devices, Inc.Â
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of repositioning and offloading devices is estimated at USD 3.39 billion.
The global repositioning and offloading devices market size was more than USD 3.22 billion in 2025 and is anticipated to grow at a CAGR of over 6%, reaching USD 5.77 billion revenue by 2035.
The North America repositioning and offloading devices market is anticipated to capture a 35% revenue share by 2035, attributed to its advanced healthcare infrastructure and growing burden of pressure injuries
Key players in the market include Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi-aventis Groupe, AdvoCare International, Hikma Pharmaceuticals PLC, Henry Schein, Inc., Fresenius Kabi USA, Pfizer Inc.
